Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04358185
Title Itacitinib in Advanced Hepatocellular Carcinoma (JAKaL)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Imperial College London
Indications

hepatocellular carcinoma

Therapies

Itacitinib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.